glac Biotech Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was TWD 342.656 million compared to TWD 495.486 million a year ago. Operating loss was TWD 23.567 million compared to operating Income of TWD 95.005 million a year ago. Net loss was TWD 13.646 million compared to net income of TWD 55.287 million a year ago. Basic loss per share was TWD 0.19 compared to basic earnings per share of TWD 0.77 a year ago. Diluted eps was TWD 0 compared to TWD 0.76 a year ago.